IGF1 and Anxiety: As a therapeutic approach we performed the intracisternal administration of a recombinant adenoviral vector encoding IGF-1 (RAd IGF-1) one week after 6-OHDA-induced neurotoxicity.<h4>Results</h4>At a behavioral level, IGF-1 treatment effectively prevented anxiety-like behavior by the third week of neurotoxicity.